139 related articles for article (PubMed ID: 6395564)
1. [Carcinogen screening in mammalian cells in vitro. The clastogenicity and the SCE test].
Thust R
Zentralbl Allg Pathol; 1984; 129(4):365-70. PubMed ID: 6395564
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
Kirkland D; Aardema M; Henderson L; Müller L
Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
[TBL] [Abstract][Full Text] [Related]
3. [Quantitative evaluation of the effectiveness of the formation of sister chromatid exchanges and chromosome aberrations as affected by chemical mutagens].
Shcheglova EG; Chebotarev AN
Tsitol Genet; 1984; 18(4):298-301. PubMed ID: 6474568
[TBL] [Abstract][Full Text] [Related]
4. Chromosome aberration and sister chromatid exchange tests in Chinese hamster ovary cells in vitro. III. Results with 27 chemicals.
Gulati DK; Witt K; Anderson B; Zeiger E; Shelby MD
Environ Mol Mutagen; 1989; 13(2):133-93. PubMed ID: 2917552
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms in metal genotoxicity: the significance of in vitro approaches.
Léonard A
Mutat Res; 1988 Apr; 198(2):321-6. PubMed ID: 3280986
[TBL] [Abstract][Full Text] [Related]
6. Interindividual variation of carcinogen activation by human liver homogenates. A study using dimethylnitrosamine (DMN) and cyclophosphamide (CP) as precursor genotoxic agents and clastogenicity and induction of sister chromatid exchanges in Chinese hamster V79-E cells as endpoints.
Thust R
Arch Geschwulstforsch; 1982; 52(2):97-104. PubMed ID: 7103690
[TBL] [Abstract][Full Text] [Related]
7. Transformed roots of Crepis capillaris--a [corrected] sensitive system for the evaluation of the clastogenicity of abiotic agents.
Juchimiuk J; Maluszynska J
Mutat Res; 2005 Jan; 565(2):129-38. PubMed ID: 15661611
[TBL] [Abstract][Full Text] [Related]
8. The results of assays in Drosophila as indicators of exposure to carcinogens.
Vogel EW; Graf U; Frei HJ; Nivard MM
IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
[TBL] [Abstract][Full Text] [Related]
9. Sister chromatid exchange (SCE) and structural chromosome aberration in mutagenicity testing.
Gebhart E
Hum Genet; 1981; 58(3):235-54. PubMed ID: 6459983
[TBL] [Abstract][Full Text] [Related]
10. Use of the mudminnow, Umbra sp., in an in vivo sister chromatid exchange test.
Kligerman AD; Bishop WE; Valentine LC
Natl Cancer Inst Monogr; 1984 May; 65():111-8. PubMed ID: 6749245
[TBL] [Abstract][Full Text] [Related]
11. Multiple-endpoint mutagenesis with Chinese hamster ovary (CHO) cells: evaluation with eight carcinogenic and non-carcinogenic compounds.
Hsie AW; San Sebastian JR; Perdue SW; Schenley RL; Waters MD
Mol Toxicol; 1987; 1(2-3):217-34. PubMed ID: 3449758
[TBL] [Abstract][Full Text] [Related]
12. [Dynamics of the frequencies of sister chromatid exchange and chromosome aberrations in vivo].
Stukalov SV
Biull Eksp Biol Med; 1988 Aug; 106(8):220-1. PubMed ID: 3137980
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of sister chromatid exchange and micronuclei as biological endpoints.
Sorsa M
IARC Sci Publ; 1984; (59):339-49. PubMed ID: 6545285
[TBL] [Abstract][Full Text] [Related]
14. Sister chromatid exchange and chromosome aberration analysis with the use of several carcinogens and noncarcinogens.
Popescu NC; Turnbull D; DiPaolo JA
J Natl Cancer Inst; 1977 Jul; 59(1):289-93. PubMed ID: 406414
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of the feasibility of using cytogenetic damage as a biomarker for alachlor exposure.
Kligerman AD; Erexson GL
Mutat Res; 1999 Apr; 441(1):95-101. PubMed ID: 10224326
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the bioluminescence assays as screens for genotoxic chemicals.
Elmore E; Fitzgerald MP
Prog Clin Biol Res; 1990; 340D():379-87. PubMed ID: 2371306
[TBL] [Abstract][Full Text] [Related]
17. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays.
Tennant RW; Margolin BH; Shelby MD; Zeiger E; Haseman JK; Spalding J; Caspary W; Resnick M; Stasiewicz S; Anderson B
Science; 1987 May; 236(4804):933-41. PubMed ID: 3554512
[TBL] [Abstract][Full Text] [Related]
18. Absence of genotoxicity in human blood cells exposed to 50 Hz magnetic fields as assessed by comet assay, chromosome aberration, micronucleus, and sister chromatid exchange analyses.
Stronati L; Testa A; Villani P; Marino C; Lovisolo GA; Conti D; Russo F; Fresegna AM; Cordelli E
Bioelectromagnetics; 2004 Jan; 25(1):41-8. PubMed ID: 14696052
[TBL] [Abstract][Full Text] [Related]
19. Genetic toxicity assessment: employing the best science for human safety evaluation part III: the comet assay as an alternative to in vitro clastogenicity tests for early drug candidate selection.
Witte I; Plappert U; de Wall H; Hartmann A
Toxicol Sci; 2007 May; 97(1):21-6. PubMed ID: 17204584
[TBL] [Abstract][Full Text] [Related]
20. [Chromatid exchanges: a chromosomal index of environmental mutagenicity].
Ercolanelli M; Stanyon R; Chiarelli B
Minerva Med; 1986 Aug; 77(32-33):1477-9. PubMed ID: 3736985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
